The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.
Legend Biotech Corp (NASDAQ:LEGN)
- On July 13, JP Morgan analyst Jessica Fye reinstated Legend Biotech with a Neutral and announced a $35 price target. The company’s stock fell around 20% over the past month and has a 52-week low of $16.25.
- RSI Value: 28.4
- LEGN Price Action: Shares of Legend Biotech fell 2% to close at $22.26 on Friday.
- Edge Stock Ratings: 13.67 Momentum score.
Opus Genetics Inc (NASDAQ:IRD)
Anbio Biotechnology (NASDAQ:NNNN)
BZ Edge Rankings: Find out where other stocks stand—explore the full comparison now.
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.